Developer docs
API playgroundTry for free, no card

Search company profiles

Newtopia

Full company profile

uuid0005eha

Namestring
Newtopia
Legal namestring
Newtopia Inc.
Websiteurl
newtopia.com
Company typeenum
Public
Founded yearint
2008
Descriptiontext

Newtopia Inc. is a Toronto-headquartered digital health company that operates a habit-change platform targeting chronic disease prevention and reversal for participants reached through self-insured employers and health insurer distribution channels. The platform combines a proprietary 7-gene genetic testing panel, an Inspirator matching algorithm that pairs participants with dedicated human health coaches, and the Habit Change Index (HCI) — a proprietary scoring system aggregating activity, sleep, stress, meals, mood, and adherence data to track behavioral change. Newtopia offers seven condition-specific program modules (Hypertension, Diabetes, Weight Management, Anxiety and Depression, Metabolic Disease, Musculoskeletal, and GLP-1 Sustain) plus optional smart-tech kits (wearable activity tracker and connected scale) delivered through a mobile and web application.

The company operates a B2B2C go-to-market: enterprise field sales target Fortune 500 self-insured employers and health insurers/payviders, who then provide Newtopia to their employees or members as a benefit. Revenue is generated through multi-year subscription contracts at approximately C$1,600 per participant over a three-year engagement window, with engagement-based pricing tying payment to participation. Distribution includes employer benefits programs, health-plan insurance offerings, and the newly announced partnership with a US Supplemental Payvider covering millions of employee lives. The company is publicly traded on TSXV (NEWU) and OTCQB (NEWUF), has 51-100 employees, and maintains offices in Toronto and New York.

Financially, Newtopia reported Q3 2024 revenue of $1.0 million, a 59% year-over-year decline attributed to a single client loss in June 2024 plus a structural incentive change with an existing client. The company has funded operations through a long history of small and mid-sized private placements and a C$7.5 million bought-deal round in March 2024 led by Bloom Burton Securities, followed by a $2 million debt financing in May 2025 specifically earmarked for GLP-1 platform integration and a stated objective of reaching cash-flow positive in 2025. Clinical validation includes CDC program recognition and published randomized controlled trial outcomes (14.5% metabolic severity risk reduction, 10 mm Hg systolic blood pressure reduction, 3.4% A1c reduction, 70% participant weight-loss participation), positioning the platform in the evidence-based digital therapeutics segment.

Short descriptiontext

Newtopia is a Toronto-based digital health company operating a habit-change platform that combines genetic testing, AI-supported health-coach matching, and a proprietary progress index to prevent chronic disease for self-insured employers' employees and health-plan members via a B2B2C subscription model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
chronic disease prevention, digital health platform, habit change coaching, metabolic health programs, employee wellness benefits
Industry2 codes
PRIMARYHLALADAK
Virtual Preventive Care & Wellness Coaching (incl. lifestyle medicine)
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
SECONDARYHLAAANAL
Population Genomics & Preventive Precision Health Programs
NAICS code2 codes
  • Diet and Weight Reducing Centers812191
  • Outpatient Mental Health and Substance Abuse Centers621420
Product category
Digital Health Platform - Chronic Disease Prevention
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Subscription/B2B2C Revenue
TypeSubscription Recurring
Description

Newtopia generates recurring subscription revenue through contracts with self-insured employers and health insurers. The company earns revenue per participant over multi-year contract periods, with engagement-based pricing ensuring ROI for customers. Revenue per participant is approximately $1,600 over a three-year period.

newtopia.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise B2B2C subscription model with engagement-based pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Engagement-based pricing ensures investment delivers value. Revenue per participant approximately $1,600 over three-year period. No per-user pricing publicly disclosed.

newtopia.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1GLP-1 Sustain
Description

Newtopia's companion program that specifically supports and extends the dramatic clinical outcomes produced by GLP-1 receptor agonists, helping users sustain weight loss whether they remain on or stop taking these medications.

newtopia.com
Core offering1 text field

Newtopia is a tech-enabled habit change platform for metabolic health that combines personal health coaching (Inspirators), a proprietary Habit Change Index (HCI), genetic testing, and wearable device integration to help participants prevent, slow, or reverse chronic diseases including type 2 diabetes, obesity, heart disease, and mental health conditions. The platform is offered through employer benefit programs and health plan insurance offerings as a B2B2C subscription service, with program modules covering hypertension, diabetes, weight management, anxiety and depression, metabolic disease, musculoskeletal issues, and GLP-1 medication sustainment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 14.5% decrease in metabolic severity risk among participants
+8 more records
Product overview1 text field

Newtopia is a tech-enabled habit change platform for metabolic health, operating as a unified platform-plus-modules architecture. The core platform combines personal health coaching (Inspirators) with proprietary technology including the Habit Change Index (HCI) tracking metric, genetic analysis, and smart digital tools. The platform offers seven specialized program modules: Hypertension, Diabetes, Weight Management, Anxiety and Depression, Metabolic Disease, MSK (Musculoskeletal), and GLP-1 Sustain. Add-on features include genetic testing and wearable device integration. Programs are offered through employers and health plans as employee/member benefits, and are clinically proven through randomized controlled trials with CDC recognition.

Product and service7 records
1Newtopia for Hypertension
CategoryChronic Disease Prevention Program
Description

A program helping participants with high blood pressure develop healthy habits that lower risk of heart disease and stroke, delivering a 10mm Hg reduction in systolic blood pressure.

2Newtopia for Diabetes
CategoryChronic Disease Prevention Program
Description

Program helping individuals with pre-diabetes or diagnosed type 2 diabetes develop sustainable healthy habits to reduce blood glucose, lower insulin resistance, and improve physical and mental health.

3Newtopia for Weight Management
CategoryChronic Disease Prevention Program
Description

Weight loss program that helps participants achieve healthy weight loss through sustainable positive habits with dedicated one-on-one health coaching support.

4Newtopia for Anxiety and Depression
CategoryMental Health Program
Description

Mental health program using cognitive behavioral therapy (CBT) techniques to help participants recognize emotional triggers, manage stress, and develop sustainable positive behaviors.

5Newtopia for Metabolic Disease
CategoryChronic Disease Prevention Program
Description

Program addressing metabolic disease risk factors including high blood sugar, high blood pressure, elevated triglycerides, high BMI, and low HDL cholesterol through sustainable healthy habit development.

6Newtopia for MSK (Musculoskeletal)
CategoryChronic Disease Prevention Program
Description

Program addressing arthritis, fibromyalgia, and pain conditions to help participants reduce pain, decrease medications, and develop sustainable healthy habits for better mobility.

7GLP-1 Sustain
CategoryMedication Companion Program
Description

Companion program supporting GLP-1 medication users (Wegovy, Ozempic, Mounjaro) to sustain weight loss and develop lifestyle habits once users encounter weight loss plateau or discontinue medication.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Digital chronic disease prevention and management platform serving self-insured employers and health plans with coaching, connected devices, and behavioral programs for diabetes, hypertension, and weight management — directly overlapping Newtopia's B2B2C enterprise model and program mix.

TypeDirect peer
Description

Clinically validated digital diabetes reversal and metabolic health platform sold to employers and health plans, with similar emphasis on coaching, outcomes-based pricing, and chronic disease cost reduction.

3Noom
TypeDirect peer
Description

Consumer and employer-facing habit change and weight management platform using coaching, psychology-based content, and personalization — competing directly for the same employer wellness and chronic disease prevention budgets.

TypeBroad incumbent
Description

Large incumbent digital chronic condition management platform offering coaching, connected devices, and behavioral programs across diabetes, hypertension, and mental health, sold primarily to employers and payers at scale.

TypeDirect peer
Description

AI-driven digital coaching platform for chronic disease prevention (diabetes, hypertension, prediabetes) sold to health plans and employers, with comparable coaching-led engagement model.

TypeDirect peer
Description

Vendor of worksite and virtual wellness coaching programs to employers and health plans, providing lifestyle and habit change coaching in a similar B2B2C distribution structure.

TypeEmerging player
Description

Employer-focused mental health benefit platform with coaching and therapy services — overlapping with Newtopia's anxiety/depression program and competing for the same employer wellness budget line items.

TypeEmerging player
Description

Employer-paid mental health platform combining coaching, therapy, and measurement — competing for the same employer wellness dollars as Newtopia's mental health program module.

TypeDirect peer
Description

Health engagement and chronic disease risk screening platform sold to health plans and retailers that helps participants track and act on health metrics — adjacent to Newtopia's connected device and engagement-based model.

TypeBroad incumbent
Description

Digital consumer and employer wellness platform owned by Optum offering incentive-based wellness programs, chronic condition support, and habit change content — broader portfolio but overlapping use cases for the same employer buyers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds17 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Newtopia

Digital Health Platform - Chronic Disease Preventionnewtopia.com

Newtopia is a Toronto-based digital health company operating a habit-change platform that combines genetic testing, AI-supported health-coach matching, and a proprietary progress index to prevent chronic disease for self-insured employers' employees and health-plan members via a B2B2C subscription model.

What Newtopia does

Newtopia Inc. is a Toronto-headquartered digital health company that operates a habit-change platform targeting chronic disease prevention and reversal for participants reached through self-insured employers and health insurer distribution channels. The platform combines a proprietary 7-gene genetic testing panel, an Inspirator matching algorithm that pairs participants with dedicated human health coaches, and the Habit Change Index (HCI) — a proprietary scoring system aggregating activity, sleep, stress, meals, mood, and adherence data to track behavioral change. Newtopia offers seven condition-specific program modules (Hypertension, Diabetes, Weight Management, Anxiety and Depression, Metabolic Disease, Musculoskeletal, and GLP-1 Sustain) plus optional smart-tech kits (wearable activity tracker and connected scale) delivered through a mobile and web application.

The company operates a B2B2C go-to-market: enterprise field sales target Fortune 500 self-insured employers and health insurers/payviders, who then provide Newtopia to their employees or members as a benefit. Revenue is generated through multi-year subscription contracts at approximately C$1,600 per participant over a three-year engagement window, with engagement-based pricing tying payment to participation. Distribution includes employer benefits programs, health-plan insurance offerings, and the newly announced partnership with a US Supplemental Payvider covering millions of employee lives. The company is publicly traded on TSXV (NEWU) and OTCQB (NEWUF), has 51-100 employees, and maintains offices in Toronto and New York.

Financially, Newtopia reported Q3 2024 revenue of $1.0 million, a 59% year-over-year decline attributed to a single client loss in June 2024 plus a structural incentive change with an existing client. The company has funded operations through a long history of small and mid-sized private placements and a C$7.5 million bought-deal round in March 2024 led by Bloom Burton Securities, followed by a $2 million debt financing in May 2025 specifically earmarked for GLP-1 platform integration and a stated objective of reaching cash-flow positive in 2025. Clinical validation includes CDC program recognition and published randomized controlled trial outcomes (14.5% metabolic severity risk reduction, 10 mm Hg systolic blood pressure reduction, 3.4% A1c reduction, 70% participant weight-loss participation), positioning the platform in the evidence-based digital therapeutics segment.

Newtopia firmographics

Firmographics
Name
Newtopia
Legal name
Newtopia Inc.
Website
https://newtopia.com
Company type
Public
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Short description
Newtopia is a Toronto-based digital health company operating a habit-change platform that combines genetic testing, AI-supported health-coach matching, and a proprietary progress index to prevent chronic disease for self-insured employers' employees and health-plan members via a B2B2C subscription model.
Ownership category
akta.pro rank

Newtopia industry classification

Industry
Product category
Digital Health Platform - Chronic Disease Prevention
NAICS
Diet and Weight Reducing Centers (812191), Outpatient Mental Health and Substance Abuse Centers (621420)
akta.pro industry
PRIMARYHLALADAK
Virtual Preventive Care & Wellness Coaching (incl. lifestyle medicine)
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
SECONDARYHLAAANAL
Population Genomics & Preventive Precision Health Programs

Keywords

  • Chronic disease prevention
  • Digital health platform
  • Habit change coaching
  • Metabolic health programs
  • Employee wellness benefits

Where Newtopia is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Newtopia business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Subscription/B2B2C Revenue: Newtopia generates recurring subscription revenue through contracts with self-insured employers and health insurers. The company earns revenue per participant over multi-year contract periods, with engagement-based pricing ensuring ROI for customers. Revenue per participant is approximately $1,600 over a three-year period.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise B2B2C subscription model with engagement-based pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Newtopia product offering

Product offering

Core offering

Newtopia is a tech-enabled habit change platform for metabolic health that combines personal health coaching (Inspirators), a proprietary Habit Change Index (HCI), genetic testing, and wearable device integration to help participants prevent, slow, or reverse chronic diseases including type 2 diabetes, obesity, heart disease, and mental health conditions. The platform is offered through employer benefit programs and health plan insurance offerings as a B2B2C subscription service, with program modules covering hypertension, diabetes, weight management, anxiety and depression, metabolic disease, musculoskeletal issues, and GLP-1 medication sustainment.

Product overview

Newtopia is a tech-enabled habit change platform for metabolic health, operating as a unified platform-plus-modules architecture. The core platform combines personal health coaching (Inspirators) with proprietary technology including the Habit Change Index (HCI) tracking metric, genetic analysis, and smart digital tools. The platform offers seven specialized program modules: Hypertension, Diabetes, Weight Management, Anxiety and Depression, Metabolic Disease, MSK (Musculoskeletal), and GLP-1 Sustain. Add-on features include genetic testing and wearable device integration. Programs are offered through employers and health plans as employee/member benefits, and are clinically proven through randomized controlled trials with CDC recognition.

Differentiator

Problem solved

Functional benefit

Brands

  • GLP-1 Sustain: Newtopia's companion program that specifically supports and extends the dramatic clinical outcomes produced by GLP-1 receptor agonists, helping users sustain weight loss whether they remain on or stop taking these medications.

Products and services

  • Newtopia for Hypertension A program helping participants with high blood pressure develop healthy habits that lower risk of heart disease and stroke, delivering a 10mm Hg reduction in systolic blood pressure.
  • Newtopia for Diabetes Program helping individuals with pre-diabetes or diagnosed type 2 diabetes develop sustainable healthy habits to reduce blood glucose, lower insulin resistance, and improve physical and mental health.
  • Newtopia for Weight Management Weight loss program that helps participants achieve healthy weight loss through sustainable positive habits with dedicated one-on-one health coaching support.
  • Newtopia for Anxiety and Depression Mental health program using cognitive behavioral therapy (CBT) techniques to help participants recognize emotional triggers, manage stress, and develop sustainable positive behaviors.
  • Newtopia for Metabolic Disease Program addressing metabolic disease risk factors including high blood sugar, high blood pressure, elevated triglycerides, high BMI, and low HDL cholesterol through sustainable healthy habit development.
  • Newtopia for MSK (Musculoskeletal) Program addressing arthritis, fibromyalgia, and pain conditions to help participants reduce pain, decrease medications, and develop sustainable healthy habits for better mobility.
  • GLP-1 Sustain Companion program supporting GLP-1 medication users (Wegovy, Ozempic, Mounjaro) to sustain weight loss and develop lifestyle habits once users encounter weight loss plateau or discontinue medication.

Quantifiable outcome

  • 14.5% decrease in metabolic severity risk among participants
  • +8 more outcomes

Companies that use Newtopia

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Newtopia technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Newtopia partnerships and signals

Strategic signal

Scale indicators16 records

Recent moves6 records

Expansion highlights5 records

Newtopia competitors and assessment

Company assessment

Direct peers

  • Omada Health: Digital chronic disease prevention and management platform serving self-insured employers and health plans with coaching, connected devices, and behavioral programs for diabetes, hypertension, and weight management — directly overlapping Newtopia's B2B2C enterprise model and program mix.
  • Virta Health: Clinically validated digital diabetes reversal and metabolic health platform sold to employers and health plans, with similar emphasis on coaching, outcomes-based pricing, and chronic disease cost reduction.
  • Noom: Consumer and employer-facing habit change and weight management platform using coaching, psychology-based content, and personalization — competing directly for the same employer wellness and chronic disease prevention budgets.
  • Lark Health: AI-driven digital coaching platform for chronic disease prevention (diabetes, hypertension, prediabetes) sold to health plans and employers, with comparable coaching-led engagement model.
  • Wellness Coaches USA: Vendor of worksite and virtual wellness coaching programs to employers and health plans, providing lifestyle and habit change coaching in a similar B2B2C distribution structure.
  • Higi (Higi/Stayhealthy): Health engagement and chronic disease risk screening platform sold to health plans and retailers that helps participants track and act on health metrics — adjacent to Newtopia's connected device and engagement-based model.

Broad incumbents

  • Livongo (Teladoc Health): Large incumbent digital chronic condition management platform offering coaching, connected devices, and behavioral programs across diabetes, hypertension, and mental health, sold primarily to employers and payers at scale.
  • Rally Health (Optum): Digital consumer and employer wellness platform owned by Optum offering incentive-based wellness programs, chronic condition support, and habit change content — broader portfolio but overlapping use cases for the same employer buyers.

Emerging players

  • Lyra Health: Employer-focused mental health benefit platform with coaching and therapy services — overlapping with Newtopia's anxiety/depression program and competing for the same employer wellness budget line items.
  • Spring Health: Employer-paid mental health platform combining coaching, therapy, and measurement — competing for the same employer wellness dollars as Newtopia's mental health program module.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Newtopia social profiles

Digital presence

Newtopia compliance and trust

Trust signal

Compliance2 records

Newtopia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Newtopia leadership team

Management profile

Number of profiles

Profiles17 records

Newtopia funding detail

Funding detail

Funding overview

Funding rounds17 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Newtopia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Newtopia

What does Newtopia do?

Newtopia is a tech-enabled habit change platform for metabolic health that combines personal health coaching (Inspirators), a proprietary Habit Change Index (HCI), genetic testing, and wearable device integration to help participants prevent, slow, or reverse chronic diseases including type 2 diabetes, obesity, heart disease, and mental health conditions. The platform is offered through employer benefit programs and health plan insurance offerings as a B2B2C subscription service, with program modules covering hypertension, diabetes, weight management, anxiety and depression, metabolic disease, musculoskeletal issues, and GLP-1 medication sustainment.

Is Newtopia a public or private company?

Newtopia is a public company. It is classified as public and is currently operating.

When was Newtopia founded?

Newtopia was founded in 2008. It employs 11 to 50 people.

Where is Newtopia based?

Newtopia is headquartered in Toronto, Canada, in the North America region.

How does Newtopia make money?

One revenue line is on record: subscription/B2B2C Revenue.

Who are Newtopia's main competitors?

Direct peers on record are Omada Health, Virta Health, Noom, Lark Health, Wellness Coaches USA and Higi (Higi/Stayhealthy). Broad incumbents are Livongo (Teladoc Health) and Rally Health (Optum). Emerging players are Lyra Health and Spring Health.

Does Newtopia have an API?

No public API is recorded for Newtopia.

What industry is Newtopia in?

Newtopia's product category is Digital Health Platform - Chronic Disease Prevention. Its primary akta.pro industry code is HLALADAK, Virtual Preventive Care & Wellness Coaching (incl. lifestyle medicine), with a secondary code of HLAAANAL, Population Genomics & Preventive Precision Health Programs. Its NAICS code is 812191.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mexico Business NewsPulpos Raises US$5 Million Led by Dalus Capital for POS ExpansionPulpos raised US$5 million led by Dalus Capital to integrate AI agents into its WhatsApp-based POS platform for Mexican SMEs. The funding targets low AI adoption (0.1% among microbusinesses) and automates inventory and debt management. The company serves over 5,000 active sellers and plans to open physical offices in major Mexican cities.NewsfileNewtopia Completes $2 Million Debt Financing, Assignment of Existing Senior Secured Credit Facility and Provides Corporate UpdateNewtopia completed a transaction adding $1.6 million in new senior secured debt and settling $0.4 million owed to officers and directors. The consolidated facility has a 2-year term at 15% interest, with no payments until maturity. The company plans to use proceeds for working capital and aims to reach cash flow positive status in 2025.PR NewswireNewtopia Reports Third Quarter 2024 Financial ResultsNewtopia Inc. reported Q3 2024 financial results showing revenue of $1.0 million, a 59% decline from $2.4 million in the prior-year period, driven by the loss of a client in June 2024 and a structural incentive change with an existing client. The company posted an adjusted operating loss of $987 thousand compared to a $21 thousand gain in Q3 2023, with gross profit margin contracting to 34% from 57%. The company announced a new partnership with a US supplemental payvider covering millions of employee lives and stated it anticipates returning to profitable growth in 2025.NewswireNEWTOPIA ANNOUNCES BRIDGE LOAN FROM BLOOM BURTON & CO.Newtopia Inc. has secured a CDN$200,000 bridge loan from Bloom Burton & Co. Inc. to fund working capital and general administrative purposes while advancing its strategic process. The loan carries a 12% annual interest rate and is payable upon demand, with the company noting it will require additional financing to meet its obligations.PR NewswireNewtopia Schedules Second Quarter 2024 Earnings Release and Conference CallNewtopia Inc. announced it will release its second quarter 2024 financial results after market close on Thursday, August 8, 2024. The company will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results in further detail, with dial-in and webcast access details provided. Newtopia is a tech-enabled whole health platform listed on the TSXV under ticker NEWU and on the OTCQB under ticker NEWUF.PR NewswireNewtopia Schedules Combined Fourth Quarter 2023 and First Quarter 2024 Earnings Release and Conference CallNewtopia Inc. announced it will release combined financial results for Q4 2023 and Q1 2024 after market close on May 23, 2024, with a conference call scheduled for 5:00 p.m. Eastern Time that same day. The company will discuss the quarterly results in detail during the call, which can be accessed via dial-in numbers or live webcast. Newtopia is a tech-enabled whole health platform listed on the TSXV under the ticker NEWU and on the OTCQB under NEWUF.NewtopiaNewtopia announces closing of C$7.5 Million bought deal offeringNewtopia Inc. has closed a C$7.5 million bought deal private placement offering of 7,900,000 units at $0.95 per unit, led by underwriters Bloom Burton Securities Inc., Stifel GMP, and INFOR Financial Inc. The net proceeds from this oversubscribed equity offering will be used to repay indebtedness and fund general working capital for the tech-enabled disease prevention company.NewswireNewtopia Announces Closing of $746,500 OfferingNewtopia Inc. announced the closing of a brokered private placement offering 14,430,000 units at $0.05 per unit, generating $721,500 in gross proceeds, alongside a non-brokered placement for an additional $25,000. The company will use the net proceeds to fund general working capital and corporate purposes, with insiders subscribing to $55,500 worth of units. Bloom Burton Securities Inc. acted as the agent for the brokered offering.TipranksNewtopia Inc. Completes $746.5K Private PlacementNewtopia Inc. has completed a private placement offering valued at $746,500, consisting of over 14 million units including common shares and warrants. The company intends to use the proceeds to boost general working capital and support corporate purposes.MarketScreenerNewtopia Inc. announced that it has received CAD 0.7465 million in fundingNewtopia Inc. announced the completion of a private placement raising CAD 746,500 through the issuance of 14,930,000 units at CAD 0.05 per unit on February 29, 2024. The transaction included participation from CEO Jeff Ruby and directors Roger Poirier and Hugh G. McCauley, with securities subject to a hold period expiring June 30, 2024. The offering remains subject to final acceptance by the TSX Venture Exchange.